• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Heme oxygenases, intrinsic defense system, as a novel therapeutic target for atherosclerotic disorders

Research Project

Project/Area Number 14570682
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionFukushima Medical University

Principal Investigator

ISHIKAWA Kazunobu  Fukushima Medical University, The first internal medicine, Lecturer, 医学部, 講師 (80222959)

Co-Investigator(Kenkyū-buntansha) YAOITA Hiroyuki  Fukushima Medical University, The first internal medicine, Lecturer, 医学部, 講師 (50264544)
MARUYAMA Yukio  Fukushima Medical University, The first internal medicine, Professor, 医学部, 教授 (90004712)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 2002: ¥2,700,000 (Direct Cost: ¥2,700,000)
Keywordsheme oxygenase / atherosclerosis / vascular injury / macrophage / oxygen radical / oxidized LDL / vascular endothelial cell / 虚血心筋 / 急性心筋梗塞 / 酸化ストレス
Research Abstract

Heme oxygenase (HO), an enzyme essential for heme degradation, shows anti-oxidative and anti-inflammatory properties via the production of bile pigmehts, carbon monoxide (CO) and ferritin induction under various pathophysiological conditions. A number of recent studies have shown biological effects of HO reaction in cardiovascular disorders. An inducible form of HO, H0-1, is induced by a variety of stresses such as oxidized lipoproteins, cytokines, hemodynamic changes, angiotensin II and nitric oxide (NO) in vascular wall. In this grant period, we observed that H0-1 induction seems to function as an adaptive response against these injurious stimuli. H0-1 induction in artery wall scavenged reactive oxygen species, which leads to the attenuation of monocyte adhesion and chemotaxis. H0-1 induction also reduces lipid peroxidation in plasma and artery wall. These properties of H0-1 suggest anti-atherogenic roles of this enzyme. We also examined the roles of endothelial H0-1 expression and bilirubin in atherogenesis. HO-1 also seems to play a significant role in restenosis after angioplasty, which is a major clinical problem associated with atherosclerosis. As a clinical research, we investigated the changes of the levels of biopyrrins in the patients with acute myocardial infarction. human HO-1 genetics supports these experimental results. We are currently continuing the research, which will solve current problems in various cardiovascular disorders.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Ishikawa, K: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders."Current Pharmaceutical Design.. 9. 2489-2497 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Araujo, JA: "Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse."J.Immunol. 171. 1572-1580 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Goto, J: "Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload."J.Antioxid.Redox Signal. 4. 563-568 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ishikawa, K: "Anti-atherogenic properties of heme oxygenase. In Heme oxygenase in Biology and Medicine"Kluwer Academic/Plenum Publishers, New York, USA. 8(293-301) (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ishikawa K.: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders."Current Pharmaceutical Design. 9. 2489-2497 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Araujo JA: "Systemic rather than local heme oxygenase-1 overexpression impression improves cardiac allograft outcomes in a new transgenic mouse."J. Immunol.. 171. 1572-1580 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Goto J: "Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload."J. Antioxid. Redox Signal.. 4. 563-568 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ishikawa K.: "Kluwer Academic/Plenum Publishers, New York, USA. Anti-atherogenic properties of heme oxygenase."In Heme oxygenase in Biology and Medicine. 8. 293-301 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ishikawa K: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders"Current Pharmaceutical Design. 9. 2489-2497 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Araujo JA: "Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse"J.Immunol. 171. 1572-1580 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Goto J: "Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload"J.Antioxid.Redox Signal. 4. 563-568 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Ishikawa, K: "Anti-atherogenic properties of heme oxygenase. In Heme oxygenase in Biology and Medicine"Kluwer Academic / Plenum Publishers, New York, USA. 8(293-301) (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Ishikawa, K: "Heme oxygenase-1 attenuates vascular endothelial dysfunction against pro-inflammatory stresses"Circulation. 106(19-Suppl). 273 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Goto J: "Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload"J Antioxid Redox Signal. 4. 563-568 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ishikawa, K: "Heme oxygenase as an intrinsic defense system in vascular wall : implication against atherogenesis"J Atheroscler Thromb. 8. 63-70 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ishikawa, K: "Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits"Circulation. 104. 1831-1836 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ishikawa, K.: "Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL receptor knockout mice"Circ Res. 88. 506-512 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ishikawa, K: "Anti-atherogenic properties of heme oxygenase. In Heme oxygenase in Biology and Medicine"Eds ; Abraham NG, Kluwer Academic/Plenum Publishers, New York, USA. 8(293-301) (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi